IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

SV Life Sciences Advisers, LLC

Q2 2015 Holdings

Filed 2015-08-12 | 6 holdings | $261.2K | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Entellus Medical IncCOM29363K105$90.3K3,489,53334.6%
Ophthotech CorporationCOM683745103$72.7K1,397,25627.9%
Ocular Therapeutix Inc(OCUL)COM67576A100$40.6K1,932,60715.6%
Catabasis Pharmaceuticals, Inc.COM14875P107$34.9K2,857,66713.4%
Transenterix IncCOM NEW89366M201$22.6K7,546,6928.7%